Patent · US Expired

Substituted benzimidazoles and imidazo-[4,5]-pyridines

US7271261B2 · kind B2 · utility

1Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2002
Grant dateSep 18, 2007
Priority date
Expiry dateApr 2, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

2-Aryl substituted benzimidazoles and imidazo[4,5]pyridines are disclosed as inhibitors of Cds1 and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.